Technical service
Lentivirus
more
Adeno-Associated Virus (AAV)
more
Cell Line Development
more
Cell-based Assay
more
Plasmid Construction
more
Protein Expression
more
Antibody Expression
more
Luciferase Assay
more
more
Activity Article
Genomeditech(Shanghai) Co.LTD
Genomeditech (Shanghai) Co., Ltd. was established in 2011. It is a high-tech enterprise specializing in cutting-edge biotechnological research and development. Focusing on virus packaging, Genomeditech remains at the forefront of scientific research. After fourteen years of dedicated work, it has established technical platforms with proprietary intellectual property rights in molecular biology, cell biology, virus packaging, cell line development, reporter genes, antibody expression, protein expression, and in vitro diagnostics (IVD), among others.

DDXCELL, the professional cell line sub-brand, was founded in 2020. It provides technical services and related products such as reporter gene detection, virus packaging, engineered cell construction, gene editing, and drug screening evaluation. In 2022, the vector brand “Genovector” received an upgrade. Additionally, the new reagent brand “Genoagent” was launched, covering the entire scientific research process.

Genomeditech offers customers thousands of off-the-shelf vectors and comprehensive customized services.
MORE +
14
+
years
Accumulated operations
10000
+
Cooperating Partners
2000
+
SCI Paper Citations
10000
+
Cumulative Impact Factor
20000
+
Virus Packaging
10000
+
Cell Line Development
Cooperative Unit
北大
清华
复旦
交大
川大
浙江大学
同济大学
南京医科大学
华东理工大学
青岛大学
山东大学
南京大学
吉林大学
瑞金医院
上海交通大学医学院附属仁济医院
华中科技大学同济医学院附属协和医院
海军军医大学
长海医院
复旦大学附属华山医院
南京鼓楼医院
北京协和医院
复旦大学附属中山医院
中南大学湘雅医院
浙江第一医院
阿斯利康
天境生物
再鼎医药
药明康德
上海医药
华西医院
Technical service
Lentivirus
more
Adeno-Associated Virus (AAV)
more
Cell Line Development
more
Cell-based Assay
more
Plasmid Construction
more
Protein Expression
more
Antibody Expression
more
Luciferase Assay
more
more
Activity Article
Genomeditech(Shanghai) Co.LTD
Genomeditech (Shanghai) Co., Ltd. was established in 2011. It is a high-tech enterprise specializing in cutting-edge biotechnological research and development. Focusing on virus packaging, Genomeditech remains at the forefront of scientific research. After fourteen years of dedicated work, it has established technical platforms with proprietary intellectual property rights in molecular biology, cell biology, virus packaging, cell line development, reporter genes, antibody expression, protein expression, and in vitro diagnostics (IVD), among others.

DDXCELL, the professional cell line sub-brand, was founded in 2020. It provides technical services and related products such as reporter gene detection, virus packaging, engineered cell construction, gene editing, and drug screening evaluation. In 2022, the vector brand “Genovector” received an upgrade. Additionally, the new reagent brand “Genoagent” was launched, covering the entire scientific research process.

Genomeditech offers customers thousands of off-the-shelf vectors and comprehensive customized services.
MORE +
14
+
years
Accumulated operations
10000
+
Cooperating Partners
2000
+
SCI Paper Citations
10000
+
Cumulative Impact Factor
20000
+
Virus Packaging
10000
+
Cell Line Development
Cooperative Unit
Message consultation
reset
submit
Message
Message consultation
reset
submit